RNAmed
The graduate program “RNAmed – Future Leaders in RNA-based Medicine”, which is financed by the Elite Network Bavaria (Germany), offers PhD positions (4 years) in Würzburg, Munich or Regensburg. The program started in December 2022.
RNA-based therapeutics have emerged in recent years for several diseases. With the exceptionally rapid development of RNA vaccines to counteract the SARS-CoV-2 pandemic it has become increasingly clear that RNA is on the verge of becoming another major molecule class for the fields of diagnostics, prevention and treatment of diseases.
RNAmed takes a holistic approach to endow doctoral students with the necessary knowledge and skills in the fast-growing area of RNA-based medicine.
Our group of international doctoral students is researching this exciting field and aims to develop precision medicine and targeted molecular therapeutics.
An international spirit, active networking, extracurricular activities and pharmaceutical translation are main features of RNAmed.
RNA therapeutics have the potential to revolutionize modern medicine. RNAmed takes a holistic approach to providing graduate students with the knowledge and skills necessary to launch a career in the rapidly growing field of RNA-based medicine.
We have strong ties to several biotech and pharmaceutical companies and you will have the opportunity to work there for some time in order to gather first-hand industrial experience.
International Conferences, Summer Schools, Internships
Our PhD students will have the unique opportunity to undertake cutting-edge research combining the aforementioned expertise. An interdisciplinary committee of international scientists will guide and support PhD candidates throughout their PhD. Structured mentoring and training including summer schools, industry internships, hard and soft skill workshops and opportunities to present their work at international conferences will prepare students for careers as scientists in academia or industry, as entrepreneurs or as policy makers in the broader area of RNA-based medicine.
